NovoCure20Limited  (NVCR) - NASDAQGS   Revenue / EPS Summary *      Fiscal Quarter 2016 (Fiscal Year) 2015 (Fiscal Year) 2014 (Fiscal Year) March          Revenue $13,053(t)        EPS -0.42 (3/31/2016)        Dividends N/A     June          Revenue $17,919(t)        EPS -0.48 (6/30/2016)        Dividends N/A     September          Revenue $21,674(t) $8,953(t)      EPS -0.39 (9/30/2016) -2.09 (9/30/2015)      Dividends N/A N/A   December  (FYE)          Revenue $30,242(t) $12,383(t)      EPS -0.25 (12/31/2016) 2.54 (12/31/2015)      Dividends N/A N/A   Totals          Revenue $82,888(t) $21,336(t) N/A    EPS -1.54 0.45 N/A    Dividends N/A N/A N/A Next 3 Years    Previous 3 Years
©2019, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.